Literature DB >> 25457661

Hypertrophy of the flexor hallucis longus muscle after tendon transfer in patients with chronic Achilles tendon rupture.

Maria M Oksanen1, Heidi H Haapasalo2, Petra P Elo3, Heikki-Jussi Laine4.   

Abstract

BACKGROUND: Flexor hallucis longus tendon (FHLT) transfer has become a popular method for reconstructing a chronic Achilles tendon rupture (ATR). The purpose of this study was to evaluate the clinical outcomes and possible hypertrophy of the FHL muscle after FHLT transfer in patients with chronic ATR.
METHODS: Seven patients with chronic ATR underwent an FHLT transfer to heel through single incision. The patients were clinically evaluated 27 (16-39) months after the surgery. The patient satisfaction was assessed with Achilles Tendon Total Rupture Scale (ATRS). Isokinetic strength was measured from both legs. The FHL muscle hypertrophy was evaluated from MRI of both legs. All subjects also performed a gait analysis with an instrumented walkway system (GAITRite(®)).
RESULTS: The plantar flexion strength was 16.1% (-45, 7-2, 4%) weaker in the operated leg. ATRS scores averaged 70.3. Marked hypertrophy, +52% (9-104%) of the FHL muscle was seen in the operated leg compared to the non-operated leg. The gait analysis did not show any marked pathology in any of the patients.
CONCLUSIONS: A mean hypertrophy of 52% of the FHL muscle was found after FHLT transfer for the chronic ATR. This indicates strong adaptation capacity of this muscle after FLHT transfer in situation where the function of the gastro-soleus complex was severely impaired preoperatively. The reconstruction of chronic ATR with FHLT transfer provided a good functional outcome and excellent patient satisfaction.
Copyright © 2014 European Foot and Ankle Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic Achilles tendon rupture; Flexor hallucis longus transfer

Mesh:

Year:  2014        PMID: 25457661     DOI: 10.1016/j.fas.2014.06.003

Source DB:  PubMed          Journal:  Foot Ankle Surg        ISSN: 1268-7731            Impact factor:   2.705


  8 in total

1.  Anatomical feasibility study of flexor hallucis longus transfer in treatment of Achilles tendon and posteromedial portal of ankle arthroscopy.

Authors:  Haijiao Mao; Linger Wang; Wenwei Dong; Zhenxin Liu; Weigang Yin; Dachuan Xu; Keith L Wapner
Journal:  Surg Radiol Anat       Date:  2018-04-16       Impact factor: 1.246

2.  Patient reported outcomes and satisfaction following single incision Flexor Hallucis Longus (FHL) augmentation for chronic Achilles tendon pathologies.

Authors:  Mohamed Yassin; Vatsal Gupta; Andre Martins; Devendra Mahadevan; Maneesh Bhatia
Journal:  J Clin Orthop Trauma       Date:  2021-10-19

3.  Flexor hallucis longus transfer clinical outcome through a single incision for chronic Achilles tendon rupture.

Authors:  Hossam Abubeih; Mohamed Khaled; Waleed Riad Saleh; Galal Z Said
Journal:  Int Orthop       Date:  2018-05-12       Impact factor: 3.075

4.  Surgical Strategy for the Chronic Achilles Tendon Rupture.

Authors:  Yangjing Lin; Liu Yang; Li Yin; Xiaojun Duan
Journal:  Biomed Res Int       Date:  2016-10-25       Impact factor: 3.411

Review 5.  Chronic Achilles Tendon Rupture.

Authors:  Nicola Maffulli; Alessio Giai Via; Francesco Oliva
Journal:  Open Orthop J       Date:  2017-07-31

6.  Achilles Tendon Lesions - Part 2: Ruptures.

Authors:  Nacime Salomão Barbachan Mansur; Lucas Furtado Fonseca; Fábio Teruo Matsunaga; Daniel Soares Baumfeld; Caio Augusto de Souza Nery; Marcel Jun Sugawara Tamaoki
Journal:  Rev Bras Ortop (Sao Paulo)       Date:  2020-04-29

7.  Flexor hallucis longus hypertrophy secondary to Achilles tendon tendinopathy: an MRI-based case-control study.

Authors:  Stephan H Wirth; Octavian Andronic; Fabian Aregger; Anna Jungwirth-Weinberger; Thorsten Jentzsch; Andreas Hecker
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-02-08

Review 8.  Management of chronic Achilles ruptures: a scoping review.

Authors:  Zaki Arshad; Edward Jun Shing Lau; Shu Hui Leow; Maneesh Bhatia
Journal:  Int Orthop       Date:  2021-06-05       Impact factor: 3.075

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.